Pain News and Research

Latest Pain News and Research

New method could help reduce breast-lesion biopsies

New method could help reduce breast-lesion biopsies

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

Sun Pharma acquires Chattem Chemicals, Inc

Sun Pharma acquires Chattem Chemicals, Inc

Advanced CT scans 100 percent accurate in checking for clogged arteries

Advanced CT scans 100 percent accurate in checking for clogged arteries

Baffling chronic pain linked to rewiring of brain

Baffling chronic pain linked to rewiring of brain

Discovery may lead to new therapeutic approaches for pain reduction

Discovery may lead to new therapeutic approaches for pain reduction

Mammogram most effective 12 months after radiation

Mammogram most effective 12 months after radiation

Vasovagal syncope - most common emergency situation in the dental office

Vasovagal syncope - most common emergency situation in the dental office

Signs of stroke -  most people ignorant

Signs of stroke - most people ignorant

CardioVascular BioTherapeutics doses first patient in trial for severe coronary heart disease

CardioVascular BioTherapeutics doses first patient in trial for severe coronary heart disease

Febuxostat recommended by panel for treatment of hyperuricemia in patients with gout

Febuxostat recommended by panel for treatment of hyperuricemia in patients with gout

MorphoSys granted U.S. patent on antibodies against GM-CSF to treat inflammatory disorders

MorphoSys granted U.S. patent on antibodies against GM-CSF to treat inflammatory disorders

Women more likely than men to be hospitalized for chest pain

Women more likely than men to be hospitalized for chest pain

Study shows true economic cost of living with multiple sclerosis

Study shows true economic cost of living with multiple sclerosis

King Pharmaceuticals and Alpharma sign definitive merger agreement

King Pharmaceuticals and Alpharma sign definitive merger agreement

Tapentadol hydrochloride approved for pain relief

Tapentadol hydrochloride approved for pain relief

Children with sickle cell disease have inadequate healthcare

Children with sickle cell disease have inadequate healthcare

Nplate receives positive opinion for marketing authorisation in Europe

Nplate receives positive opinion for marketing authorisation in Europe

Reminder, signs of a heart attack can be subtle

Reminder, signs of a heart attack can be subtle

FDA approves tapentadol immediate-release tablets for pain in adults

FDA approves tapentadol immediate-release tablets for pain in adults

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.